1Bell R. Bishosphonates for metastatic bone disease: a therapeutic rationale,EJC Supplements, 2004, 2:1-4.
2Diel IJ, et al. Improwed quality of life after long - term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer, 2004, 40: 1704- 1712.
3Body JJ, et al. Oral ibandronate reduces the risk of skeletal comlications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase Ⅲ studies. Br J Cancer, 2004, 90:1133 - 1137.
4Body JJ. Reducing skeletal complications and bone pain with intravenous ibandronate for metastatic bone disease.EJC Supplements, 2004, 2:5-8.
5Tripathy D. Oral daily ibandronate: an effective and convenient therapy for skeletal complications in metastatic breast cancer. EJC Supplements, 2004,2: 17-20.
